Aeon Biopharma, Stock Market Value
| AEON Stock | 1.02 0.03 2.86% |
| Symbol | AEON |
AEON Biopharma, Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AEON Biopharma,. If investors know AEON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AEON Biopharma, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AEON Biopharma, is measured differently than its book value, which is the value of AEON that is recorded on the company's balance sheet. Investors also form their own opinion of AEON Biopharma,'s value that differs from its market value or its book value, called intrinsic value, which is AEON Biopharma,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AEON Biopharma,'s market value can be influenced by many factors that don't directly affect AEON Biopharma,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AEON Biopharma,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if AEON Biopharma, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AEON Biopharma,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AEON Biopharma, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AEON Biopharma,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AEON Biopharma,.
| 11/28/2025 |
| 12/28/2025 |
If you would invest 0.00 in AEON Biopharma, on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding AEON Biopharma, or generate 0.0% return on investment in AEON Biopharma, over 30 days. AEON Biopharma, is related to or competes with Cingulate, Cellectar Biosciences, Bolt Biotherapeutics, Marker Therapeutics, OSR Holdings, Clene, and Abpro Holdings,. AEON Biopharma, is entity of United States More
AEON Biopharma, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AEON Biopharma,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AEON Biopharma, upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.82 | |||
| Information Ratio | 0.0791 | |||
| Maximum Drawdown | 48.7 | |||
| Value At Risk | (10.67) | |||
| Potential Upside | 11.96 |
AEON Biopharma, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AEON Biopharma,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AEON Biopharma,'s standard deviation. In reality, there are many statistical measures that can use AEON Biopharma, historical prices to predict the future AEON Biopharma,'s volatility.| Risk Adjusted Performance | 0.0725 | |||
| Jensen Alpha | 0.7759 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0877 | |||
| Treynor Ratio | (0.49) |
AEON Biopharma, Backtested Returns
AEON Biopharma, appears to be dangerous, given 3 months investment horizon. AEON Biopharma, secures Sharpe Ratio (or Efficiency) of 0.0816, which signifies that the company had a 0.0816 % return per unit of risk over the last 3 months. By examining AEON Biopharma,'s technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please makes use of AEON Biopharma,'s mean deviation of 5.57, and Risk Adjusted Performance of 0.0725 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AEON Biopharma, holds a performance score of 6. The firm shows a Beta (market volatility) of -1.37, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning AEON Biopharma, are expected to decrease by larger amounts. On the other hand, during market turmoil, AEON Biopharma, is expected to outperform it. Please check AEON Biopharma,'s daily balance of power, price action indicator, as well as the relationship between the semi variance and treynor ratio , to make a quick decision on whether AEON Biopharma,'s price patterns will revert.
Auto-correlation | -0.7 |
Very good reverse predictability
AEON Biopharma, has very good reverse predictability. Overlapping area represents the amount of predictability between AEON Biopharma, time series from 28th of November 2025 to 13th of December 2025 and 13th of December 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AEON Biopharma, price movement. The serial correlation of -0.7 indicates that around 70.0% of current AEON Biopharma, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
AEON Biopharma, lagged returns against current returns
Autocorrelation, which is AEON Biopharma, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AEON Biopharma,'s stock expected returns. We can calculate the autocorrelation of AEON Biopharma, returns to help us make a trade decision. For example, suppose you find that AEON Biopharma, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AEON Biopharma, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AEON Biopharma, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AEON Biopharma, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AEON Biopharma, stock over time.
Current vs Lagged Prices |
| Timeline |
AEON Biopharma, Lagged Returns
When evaluating AEON Biopharma,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AEON Biopharma, stock have on its future price. AEON Biopharma, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AEON Biopharma, autocorrelation shows the relationship between AEON Biopharma, stock current value and its past values and can show if there is a momentum factor associated with investing in AEON Biopharma,.
Regressed Prices |
| Timeline |
Pair Trading with AEON Biopharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AEON Biopharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AEON Biopharma, will appreciate offsetting losses from the drop in the long position's value.Moving against AEON Stock
| 0.5 | CMB | Cambium Bio | PairCorr |
| 0.37 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.32 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.31 | DSGN | Design Therapeutics | PairCorr |
| 0.31 | DWTX | Dogwood Therapeutics, | PairCorr |
The ability to find closely correlated positions to AEON Biopharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AEON Biopharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AEON Biopharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AEON Biopharma, to buy it.
The correlation of AEON Biopharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AEON Biopharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AEON Biopharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AEON Biopharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AEON Biopharma, Correlation, AEON Biopharma, Volatility and AEON Biopharma, Alpha and Beta module to complement your research on AEON Biopharma,. To learn how to invest in AEON Stock, please use our How to Invest in AEON Biopharma, guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
AEON Biopharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.